Satellos Bioscience MSLE
NASDAQ MSLE
$6.70 -0.30 (-4.29%)
As of: Oct 21, 2026 · 2:54 PM EDT

Satellos Bioscience (MSLE) EBIT (2025 - 2026)

Updated

Satellos Bioscience (MSLE) recorded EBIT of -$11.67 million in the quarter ended Jun 30, 2026, compared with -$5.58 million a year earlier.

Analysis

Satellos Bioscience (MSLE) EBIT (2025 - 2026) Analysis & Trends

On a TTM basis, Satellos Bioscience's EBIT came in at -$51.69 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$26.46 million.

  • Across earlier years, EBIT came in at -$19.91 million in the year ended Dec 31, 2024.
  • Quarterly EBIT has ranged from -$24.7 million in the quarter ended Dec 31, 2025 to $6.08 million in the quarter ended Mar 31, 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,136.76 Bn 1,105.35 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 618.64 Bn 537.17 Bn 17.26 Bn 7.14 Bn
3 AbbVie 502.02 Bn 475.13 Bn 12.70 Bn 6.43 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.11 Bn 234.80 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.64 Bn 192.04 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn -10.39 Bn
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 4.27 Bn
10 Satellos Bioscience 97.79 Mn -110.35 Mn - -11.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.67 Mn
Mar 31, 2026 -9.74 Mn
Jun 30, 2025 -5.58 Mn
Mar 31, 2025 6.08 Mn
API Access

Satellos Bioscience EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=MSLE&period=max&api_key=YOUR_API_KEY